Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peilin Ma

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The Journal of Clinical Investigation|June 14, 2016
S6K1 regulates hematopoietic stem cell self-renewal and leukemia maintenanceJoydeep Ghosh, Michihiro Kobayashi, Baskar Ramdas, et al.
Molecular and Cellular Biology|July 28, 2011
Balanced interactions between Lyn, the p85alpha regulatory subunit of class I(A) phosphatidylinositol-3-kinase, and SHIP are essential for mast cell growth and maturationPeilin Ma, Sasidhar Vemula, Veerendra Munugalavadla, et al.
Oncotarget|April 7, 2016
Role of p85α in neutrophil extra- and intracellular reactive oxygen species generationXing Jun Li, Lisa Deng, Stephanie L Brandt, et al.
Molecular Cell|May 7, 2016
PRDM16 Suppresses MLL1r Leukemia via Intrinsic Histone Methyltransferase ActivityBo Zhou, Jingya Wang, Shirley Y Lee, et al.
Blood|July 28, 2011
The PI3K pathway drives the maturation of mast cells via microphthalmia transcription factorPeilin Ma, Raghuveer Singh Mali, Veerendra Munugalavadla, et al.
The Journal of Clinical Investigation|October 5, 2013
Pak and Rac GTPases promote oncogenic KIT-induced neoplasmsHolly Martin, Raghuveer Singh Mali, Peilin Ma, et al.
Blood|July 19, 2012
Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KITRaghuveer Singh Mali, Peilin Ma, Li-Fan Zeng, et al.
Cancer Cell|September 13, 2011
Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3, and BCR-ABLRaghuveer Singh Mali, Baskar Ramdas, Peilin Ma, et al.
Cancer Discovery|March 17, 2019
Patient-Driven Discovery, Therapeutic Targeting, and Post-Clinical Validation of a Novel <i>AKT1</i> Fusion-Driven CancerEmily K Slotkin, Daniel Diolaiti, Neerav N Shukla, et al.
Nature Communications|January 19, 2018
The protective role of DOT1L in UV-induced melanomagenesisBo Zhu, Shuyang Chen, Hongshen Wang, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Clinical Investigation|June 14, 2016
S6K1 regulates hematopoietic stem cell self-renewal and leukemia maintenanceJoydeep Ghosh, Michihiro Kobayashi, Baskar Ramdas, et al.
Molecular and Cellular Biology|July 28, 2011
Balanced interactions between Lyn, the p85alpha regulatory subunit of class I(A) phosphatidylinositol-3-kinase, and SHIP are essential for mast cell growth and maturationPeilin Ma, Sasidhar Vemula, Veerendra Munugalavadla, et al.
Oncotarget|April 7, 2016
Role of p85α in neutrophil extra- and intracellular reactive oxygen species generationXing Jun Li, Lisa Deng, Stephanie L Brandt, et al.
Molecular Cell|May 7, 2016
PRDM16 Suppresses MLL1r Leukemia via Intrinsic Histone Methyltransferase ActivityBo Zhou, Jingya Wang, Shirley Y Lee, et al.
Blood|July 28, 2011
The PI3K pathway drives the maturation of mast cells via microphthalmia transcription factorPeilin Ma, Raghuveer Singh Mali, Veerendra Munugalavadla, et al.
The Journal of Clinical Investigation|October 5, 2013
Pak and Rac GTPases promote oncogenic KIT-induced neoplasmsHolly Martin, Raghuveer Singh Mali, Peilin Ma, et al.
Blood|July 19, 2012
Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KITRaghuveer Singh Mali, Peilin Ma, Li-Fan Zeng, et al.
Cancer Cell|September 13, 2011
Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3, and BCR-ABLRaghuveer Singh Mali, Baskar Ramdas, Peilin Ma, et al.
Cancer Discovery|March 17, 2019
Patient-Driven Discovery, Therapeutic Targeting, and Post-Clinical Validation of a Novel <i>AKT1</i> Fusion-Driven CancerEmily K Slotkin, Daniel Diolaiti, Neerav N Shukla, et al.
Nature Communications|January 19, 2018
The protective role of DOT1L in UV-induced melanomagenesisBo Zhu, Shuyang Chen, Hongshen Wang, et al.
Pageof 2